Scientists say they captured 3D images of a new organelle they're calling a "hemifusome," which may be a recycling center in ...

Three major Mount Sinai research studies offer new hope for patients facing chronic lymphocytic leukemia (CLL), a rare type ...

Free-floating DNA carrying cancerous mutations was detected in blood three years before any other signs of cancer appeared.

Specifically, the FDA removed the Risk Evaluation and Mitigation Strategy (REMS) program requirements from two BCMA-directed CAR T-cell therapies for multiple myeloma — ciltacabtagene autoleucel ...

Dr. Soma Mandal, a board-certified internist at Summit Health in New Providence, New Jersey, says that getting a CBC test is ...

Bristol Myers Squibb has announced that the FDA has given approval to label updates for Breyanzi and Abecma to treat multiple myeloma.

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...

They’ve discovered a previously unknown organelle – that is, a specialized structure that performs some specific function – inside human cells. The team named it the “hemifusome”, and in a paper ...

A new blood test can detect leukemia and blood aging risks non-invasively, potentially replacing painful bone marrow biopsies ...

A post-hoc analysis of the phase 3b JUMP trial found that ruxolitinib plus anemia supportive care maintained efficacy and reduced transfusion needs in patients with myelofibrosis.

With the Fourth of July approaching and trauma cases expected to rise, Blood Assurance is urging donors to step up now.